Standard
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. / Hasselbalch, Hans Carl; Kristiansen, Marie Hvelplund; Kjær, Lasse; Skov, Vibe; Larsen, Morten Kranker; Ellervik, Christina; Wienecke, Troels.
I:
Blood advances, Bind 8, Nr. 3, 2024, s. 681-682.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Hasselbalch, HC, Kristiansen, MH, Kjær, L, Skov, V
, Larsen, MK, Ellervik, C & Wienecke, T 2024, '
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties',
Blood advances, bind 8, nr. 3, s. 681-682.
https://doi.org/10.1182/bloodadvances.2023012190
APA
Hasselbalch, H. C., Kristiansen, M. H., Kjær, L., Skov, V.
, Larsen, M. K., Ellervik, C., & Wienecke, T. (2024).
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties.
Blood advances,
8(3), 681-682.
https://doi.org/10.1182/bloodadvances.2023012190
Vancouver
Hasselbalch HC, Kristiansen MH, Kjær L, Skov V
, Larsen MK, Ellervik C o.a.
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties.
Blood advances. 2024;8(3):681-682.
https://doi.org/10.1182/bloodadvances.2023012190
Author
Hasselbalch, Hans Carl ; Kristiansen, Marie Hvelplund ; Kjær, Lasse ; Skov, Vibe ; Larsen, Morten Kranker ; Ellervik, Christina ; Wienecke, Troels. / CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. I: Blood advances. 2024 ; Bind 8, Nr. 3. s. 681-682.
Bibtex
@article{617233ecaa3e4acd871950ef575758e4,
title = "CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties",
author = "Hasselbalch, {Hans Carl} and Kristiansen, {Marie Hvelplund} and Lasse Kj{\ae}r and Vibe Skov and Larsen, {Morten Kranker} and Christina Ellervik and Troels Wienecke",
note = "Funding Information: Conflict-of-interest disclosure: H.H. has received a research grant from Novartis and advisory fees from AOP Orphan and Incyte. The remaining authors declare no competing financial interests.",
year = "2024",
doi = "10.1182/bloodadvances.2023012190",
language = "English",
volume = "8",
pages = "681--682",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "3",
}
RIS
TY - JOUR
T1 - CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties
AU - Hasselbalch, Hans Carl
AU - Kristiansen, Marie Hvelplund
AU - Kjær, Lasse
AU - Skov, Vibe
AU - Larsen, Morten Kranker
AU - Ellervik, Christina
AU - Wienecke, Troels
N1 - Funding Information:
Conflict-of-interest disclosure: H.H. has received a research grant from Novartis and advisory fees from AOP Orphan and Incyte. The remaining authors declare no competing financial interests.
PY - 2024
Y1 - 2024
U2 - 10.1182/bloodadvances.2023012190
DO - 10.1182/bloodadvances.2023012190
M3 - Comment/debate
C2 - 38134296
AN - SCOPUS:85185484734
VL - 8
SP - 681
EP - 682
JO - Blood advances
JF - Blood advances
SN - 2473-9529
IS - 3
ER -
